Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

85 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Expert consensus on workflow of PET/CT with long axial field-of-view.
Liu G, Gu Y, Sollini M, Lazar A, Besson FL, Li S, Wu Z, Nardo L, Al-Ibraheem A, Zheng J, Kulkarni HR, Rominger A, Fan W, Zhu X, Zhao X, Wu H, Liu J, Li B, Cheng Z, Wang R, Xu B, Agostini D, Tang H, Tan L, Yang Z, Huo L, Gu J, Shi H. Liu G, et al. Among authors: kulkarni hr. Eur J Nucl Med Mol Imaging. 2024 Nov 9. doi: 10.1007/s00259-024-06968-4. Online ahead of print. Eur J Nucl Med Mol Imaging. 2024. PMID: 39520515 Review.
Rationale and design of the RAPID-WATER-FLOW trial: Radiolabeled perfusion to identify coronary artery disease using water to evaluate responses of myocardial FLOW.
Di Carli MF, Gormsen LC, Chareonthaitawee P, Johnson GB, Beanlands R, DeKemp R, Schindler T, Gropler R, Kulkarni H, McNeely P, Soman P, Oz O, Zaha V, Sorensen J, Harms H, Orlandi C, Vandenbroucke E, Udelson J. Di Carli MF, et al. J Nucl Cardiol. 2024 Jan;31:101779. doi: 10.1016/j.nuclcard.2023.101779. Epub 2023 Dec 5. J Nucl Cardiol. 2024. PMID: 38215598
Precision Imaging of Prostate Cancer.
Kulkarni HR, Alavi A. Kulkarni HR, et al. PET Clin. 2022 Oct;17(4):xiii. doi: 10.1016/j.cpet.2022.07.010. PET Clin. 2022. PMID: 36229107 No abstract available.
Salivary Gland Toxicity of PSMA-Targeted Radioligand Therapy with 177Lu-PSMA and Combined 225Ac- and 177Lu-Labeled PSMA Ligands (TANDEM-PRLT) in Advanced Prostate Cancer: A Single-Center Systematic Investigation.
Langbein T, Kulkarni HR, Schuchardt C, Mueller D, Volk GF, Baum RP. Langbein T, et al. Among authors: kulkarni hr. Diagnostics (Basel). 2022 Aug 10;12(8):1926. doi: 10.3390/diagnostics12081926. Diagnostics (Basel). 2022. PMID: 36010276 Free PMC article.
Prostate-Specific Membrane Antigen Radioligand Therapy Using 177Lu-PSMA I&T and 177Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer: Comparison of Safety, Biodistribution, and Dosimetry.
Schuchardt C, Zhang J, Kulkarni HR, Chen X, Müller D, Baum RP. Schuchardt C, et al. Among authors: kulkarni hr. J Nucl Med. 2022 Aug;63(8):1199-1207. doi: 10.2967/jnumed.121.262713. Epub 2021 Dec 9. J Nucl Med. 2022. PMID: 34887335 Free PMC article.
Feasibility, Biodistribution, and Preliminary Dosimetry in Peptide-Targeted Radionuclide Therapy of Diverse Adenocarcinomas Using 177Lu-FAP-2286: First-in-Humans Results.
Baum RP, Schuchardt C, Singh A, Chantadisai M, Robiller FC, Zhang J, Mueller D, Eismant A, Almaguel F, Zboralski D, Osterkamp F, Hoehne A, Reineke U, Smerling C, Kulkarni HR. Baum RP, et al. Among authors: kulkarni hr. J Nucl Med. 2022 Mar;63(3):415-423. doi: 10.2967/jnumed.120.259192. Epub 2021 Jun 24. J Nucl Med. 2022. PMID: 34168013 Free PMC article.
85 results